Nabriva Therapeutics Ag Stock EBITDA
NBRVDelisted Stock | USD 1.62 0.01 0.61% |
Nabriva Therapeutics AG fundamentals help investors to digest information that contributes to Nabriva Therapeutics' financial success or failures. It also enables traders to predict the movement of Nabriva Stock. The fundamental analysis module provides a way to measure Nabriva Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nabriva Therapeutics stock.
Nabriva |
Nabriva Therapeutics AG Company EBITDA Analysis
Nabriva Therapeutics' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Nabriva Therapeutics EBITDA | (54.7 M) |
Most of Nabriva Therapeutics' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nabriva Therapeutics AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, Nabriva Therapeutics AG reported earnings before interest,tax, depreciation and amortization of (54.7 Million). This is 106.23% lower than that of the Pharmaceuticals sector and 154.62% lower than that of the Health Care industry. The ebitda for all United States stocks is 101.4% higher than that of the company.
Nabriva EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nabriva Therapeutics' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nabriva Therapeutics could also be used in its relative valuation, which is a method of valuing Nabriva Therapeutics by comparing valuation metrics of similar companies.Nabriva Therapeutics is currently under evaluation in ebitda category among its peers.
Nabriva Fundamentals
Return On Equity | -2.69 | |||
Return On Asset | -0.65 | |||
Profit Margin | (1.48) % | |||
Operating Margin | (1.29) % | |||
Current Valuation | 3.29 M | |||
Shares Outstanding | 3.2 M | |||
Shares Owned By Insiders | 0.96 % | |||
Shares Owned By Institutions | 8.77 % | |||
Number Of Shares Shorted | 44.59 K | |||
Price To Earning | (0.48) X | |||
Price To Book | 0.24 X | |||
Price To Sales | 0.17 X | |||
Revenue | 35.67 M | |||
Gross Profit | (10.23 M) | |||
EBITDA | (54.7 M) | |||
Net Income | (57.19 M) | |||
Cash And Equivalents | 20.04 M | |||
Cash Per Share | 7.53 X | |||
Total Debt | 5.22 M | |||
Debt To Equity | 0.21 % | |||
Current Ratio | 2.81 X | |||
Book Value Per Share | (1.36) X | |||
Cash Flow From Operations | (36.71 M) | |||
Short Ratio | 8.58 X | |||
Earnings Per Share | (19.67) X | |||
Price To Earnings To Growth | (0.06) X | |||
Target Price | 1.0 | |||
Number Of Employees | 39 | |||
Beta | 1.56 | |||
Market Capitalization | 4.55 M | |||
Total Asset | 31.77 M | |||
Retained Earnings | (652.86 M) | |||
Working Capital | 3.5 M | |||
Current Asset | 83 M | |||
Current Liabilities | 14 M | |||
Z Score | -32.68 | |||
Net Asset | 31.77 M |
About Nabriva Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nabriva Therapeutics AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nabriva Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nabriva Therapeutics AG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Consideration for investing in Nabriva Stock
If you are still planning to invest in Nabriva Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nabriva Therapeutics' history and understand the potential risks before investing.
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |